A human monoclonal antibody blocking SARS-CoV-2 infection

Re:A human monoclonal antibody blocking SARS-CoV-2 infection by hcknwscommenter on Wednesday March 18, 2020 @02:40AM (#22614212)

~10K for an effective single-dose treatment is not that expensive. Admittedly this is a very crude calculation, but it's probably not too far off. Moreover, mAb production is a very mature technology, that can be scaled up by just growing more cells. I'm not saying we are close to getting this into the clinic, but it is a very interesting result.

[ Parent | on HN ]

Re:A human monoclonal antibody blocking SARS-CoV-2 infection by m0zg on Wednesday March 18, 2020 @03:47AM (#22614481)

Across 100M people that's a cool trillion dollars.

[ Parent | on HN ]

Re:A human monoclonal antibody blocking SARS-CoV-2 infection by newsbinator on Wednesday March 18, 2020 @04:03AM (#22614557)

True, but even if we're only talking dollars, we'd have to compare that trillion to the economic amount lost by not inoculating.

[ Parent | on HN ]

Re:A human monoclonal antibody blocking SARS-CoV-2 infection by imtringued on Wednesday March 18, 2020 @08:53AM (#22616035)

There would be a lot of dead people but the economic impact of those deaths would be pretty insignificant because highest fatality rate is for people in their 80s.

[ Parent | on HN ]

Re:A human monoclonal antibody blocking SARS-CoV-2 infection by op00to on Wednesday March 18, 2020 @12:01PM (#22618087)

I think you underestimate the psycho-social effects of having millions of deaths.

[ Parent | on HN ]